Logo image
Back
Thirty-Day Readmissions After Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis in New York State
Journal article   Open access   Peer reviewed

Thirty-Day Readmissions After Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis in New York State

Edward L Hannan, Zaza Samadashvili, Desmond Jordan, Thoralf M Sundt, 3rd, Nicholas J Stamato, Stephen J Lahey, Jeffrey P Gold, Andrew Wechsler, Mohammed H Ashraf, Carlos Ruiz, …
Circulation. Cardiovascular interventions, v 8(8), pp e002744-e002744
Aug 2015
DOI: https://doi.org/10.1161/CIRCINTERVENTIONS.115.002744
PMID: 26227347
Featured in Collection :   UN Sustainable Development Goals @ Drexel
url
https://doi.org/10.1161/circinterventions.115.002744View
Published, Version of Record (VoR)Maybe Open Access (Publisher Bronze),  Open

Abstract

Aged Aged, 80 and over Aortic Valve - surgery Aortic Valve Stenosis - diagnosis Aortic Valve Stenosis - epidemiology Aortic Valve Stenosis - surgery Female Heart Valve Prosthesis Implantation - adverse effects Humans Male Middle Aged New York - epidemiology Patient Readmission - statistics & numerical data Population Surveillance Transcatheter Aortic Valve Replacement - adverse effects
Several studies have compared short-term and medium-term mortality rates for patients with severe aortic stenosis undergoing transcatheter aortic valve implantation (TAVI) and surgical aortic valve replacement (SAVR), but no studies have compared short-term readmission rates for the 2 procedures. New York's Cardiac Surgery Reporting System was used to propensity match 617 TAVI and 1981 SAVR patients using numerous patient risk factors contained in the registry. The 389 propensity-matched pairs were then used to analyze differences in readmission rates between the 2 groups. TAVI and SAVR readmission rates were also compared for patients with a history of congestive heart failure and for patients aged ≥80. Also, reasons for readmission for TAVI and SAVR patients were examined and compared. Readmission rates were not statistically different for all propensity-matched TAVI and SAVR patients (respective rates, 18.8% and 19.3%; P=0.86). After further adjustment using a logistic regression model, there was still no significant difference (adjusted odds ratio, 0.97; 95% confidence interval [0.68-1.39]). For patients aged ≥80, the 30-day readmission rates were 19.9% and 22.0% (P=0.59), and when further adjusted using the logistic regression model, adjusted odds ratio=0.89 (0.55-1.45). For patients with a history of congestive heart failure, the respective rates were 22.8% and 20.4% (P=0.56), and with further adjustment, adjusted odds ratio became 1.15 (0.72-1.82). There are no statistically significant differences between TAVI and SAVR patients in short-term readmission rates.

Metrics

8 Record Views
41 citations in Web of Science
41 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Cardiac & Cardiovascular Systems
Logo image